These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3856277)

  • 41. Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.
    Steplewski Z; Sun LK; Shearman CW; Ghrayeb J; Daddona P; Koprowski H
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4852-6. PubMed ID: 3387441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells.
    Herlyn D; Herlyn M; Steplewski Z; Koprowski H
    Cell Immunol; 1985 Apr; 92(1):105-14. PubMed ID: 4075410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
    Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
    Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
    Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
    J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
    Houghton AN; Mintzer D; Cordon-Cardo C; Welt S; Fliegel B; Vadhan S; Carswell E; Melamed MR; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1242-6. PubMed ID: 3883355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1.
    Patel D; Balderes P; Lahiji A; Melchior M; Ng S; Bassi R; Wu Y; Griffith H; Jimenez X; Ludwig DL; Hicklin DJ; Kang X
    Hum Antibodies; 2007; 16(3-4):127-36. PubMed ID: 18334748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
    Pukel CS; Lloyd KO; Travassos LR; Dippold WG; Oettgen HF; Old LJ
    J Exp Med; 1982 Apr; 155(4):1133-47. PubMed ID: 7061953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
    Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
    Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.
    Helling F; Shang A; Calves M; Zhang S; Ren S; Yu RK; Oettgen HF; Livingston PO
    Cancer Res; 1994 Jan; 54(1):197-203. PubMed ID: 8261439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melanoma antibodies: specificity and interaction with melanoma and cytotoxic T-cells.
    Dippold WG; Knuth A; Meyer zum Büschenfelde KH
    Behring Inst Mitt; 1984 May; (74):14-8. PubMed ID: 6332614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of monoclonal antibodies to human melanoma-associated antigens.
    Imai K; Ng AK; Ferrone S
    J Natl Cancer Inst; 1981 Mar; 66(3):489-96. PubMed ID: 6162991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody-dependent cell-mediated cytotoxicity (ADCC) toward human O+ red cells coated with anti-D antibody: comparison between lymphocyte and monocyte ADCC activity.
    Sunada M; Suzuki S; Ota Z
    Acta Med Okayama; 1985 Apr; 39(2):77-89. PubMed ID: 3923782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma.
    Bajorin DF; Chapman PB; Wong GY; Cody BV; Cordon-Cardo C; Dantes L; Templeton MA; Scheinberg D; Oettgen HF; Houghton AN
    Melanoma Res; 1992 Dec; 2(5-6):355-62. PubMed ID: 1292783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-GD3 monoclonal antibody analysis of childhood T-cell acute lymphoblastic leukemia: detection of a target antigen for antibody-mediated cytolysis.
    Reaman GH; Taylor BJ; Merritt WD
    Cancer Res; 1990 Jan; 50(1):202-5. PubMed ID: 2403416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
    Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
    Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft.
    Katano M; Saxton RE; Tsuchida T; Irie RF
    Jpn J Cancer Res; 1986 Jun; 77(6):584-94. PubMed ID: 3089993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody response to immunization with purified GD3 ganglioside and GD3 derivatives (lactones, amide and gangliosidol) in the mouse.
    Ritter G; Boosfeld E; Calves MJ; Oettgen HF; Old LJ; Livingston PO
    Immunobiology; 1990 Dec; 182(1):32-43. PubMed ID: 2098322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
    Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T
    AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Separation of cell-dependent antibody (CDA) and inhibitory antibody by protein-A affinity chromatography and the effect of fractions on antibody-dependent cellular cytotoxicity (ADCC).
    Sato N; Yabuki Y; Toh K; Ishii Y; Kikuchi K
    Immunology; 1979 Mar; 36(3):421-6. PubMed ID: 437836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.